nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—CYP2A6—Fluorouracil—head and neck cancer	0.094	1	CbGbCtD
Fomepizole—CAT—Purine catabolism—GPX1—head and neck cancer	0.029	0.0618	CbGpPWpGaD
Fomepizole—CAT—exocrine gland—head and neck cancer	0.0224	0.0738	CbGeAlD
Fomepizole—ADH1B—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.0219	0.0466	CbGpPWpGaD
Fomepizole—ADH1C—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.0219	0.0466	CbGpPWpGaD
Fomepizole—CAT—hair follicle—head and neck cancer	0.0213	0.0703	CbGeAlD
Fomepizole—CAT—Vinorelbine—Vinblastine—head and neck cancer	0.021	1	CbGdCrCtD
Fomepizole—ADH1A—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.0182	0.0386	CbGpPWpGaD
Fomepizole—CAT—mouth—head and neck cancer	0.0167	0.0552	CbGeAlD
Fomepizole—ADH1A—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.0161	0.0342	CbGpPWpGaD
Fomepizole—ADH1B—mouth—head and neck cancer	0.0151	0.0497	CbGeAlD
Fomepizole—ADH1C—parotid gland—head and neck cancer	0.0149	0.049	CbGeAlD
Fomepizole—CAT—neck—head and neck cancer	0.0143	0.0472	CbGeAlD
Fomepizole—CAT—Detoxification of Reactive Oxygen Species—SOD2—head and neck cancer	0.0137	0.0292	CbGpPWpGaD
Fomepizole—CAT—Detoxification of Reactive Oxygen Species—GPX1—head and neck cancer	0.0131	0.0279	CbGpPWpGaD
Fomepizole—CAT—Oxidative Stress—SOD2—head and neck cancer	0.0126	0.0269	CbGpPWpGaD
Fomepizole—CAT—Oxidative Stress—GPX1—head and neck cancer	0.0121	0.0256	CbGpPWpGaD
Fomepizole—CAT—Oxidative Stress—CYP1A1—head and neck cancer	0.0119	0.0254	CbGpPWpGaD
Fomepizole—CAT—parotid gland—head and neck cancer	0.0117	0.0384	CbGeAlD
Fomepizole—ADH1A—trachea—head and neck cancer	0.0112	0.0369	CbGeAlD
Fomepizole—CAT—Purine metabolism—GPX1—head and neck cancer	0.0112	0.0238	CbGpPWpGaD
Fomepizole—CAT—saliva-secreting gland—head and neck cancer	0.0112	0.0368	CbGeAlD
Fomepizole—ADH1C—trachea—head and neck cancer	0.011	0.0362	CbGeAlD
Fomepizole—ADH1B—parotid gland—head and neck cancer	0.0105	0.0346	CbGeAlD
Fomepizole—CAT—Nucleotide metabolism—DPYD—head and neck cancer	0.0104	0.0221	CbGpPWpGaD
Fomepizole—CAT—connective tissue—head and neck cancer	0.0103	0.0338	CbGeAlD
Fomepizole—ADH1B—saliva-secreting gland—head and neck cancer	0.0101	0.0332	CbGeAlD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—GPX1—head and neck cancer	0.00998	0.0212	CbGpPWpGaD
Fomepizole—CAT—epithelium—head and neck cancer	0.00974	0.0321	CbGeAlD
Fomepizole—ADH1B—connective tissue—head and neck cancer	0.00924	0.0305	CbGeAlD
Fomepizole—ADH1A—thyroid gland—head and neck cancer	0.00885	0.0292	CbGeAlD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—BCL2L1—head and neck cancer	0.00882	0.0188	CbGpPWpGaD
Fomepizole—ADH1C—thyroid gland—head and neck cancer	0.00868	0.0286	CbGeAlD
Fomepizole—CAT—trachea—head and neck cancer	0.00861	0.0284	CbGeAlD
Fomepizole—CAT—FoxO family signaling—SOD2—head and neck cancer	0.00853	0.0182	CbGpPWpGaD
Fomepizole—CAT—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00848	0.018	CbGpPWpGaD
Fomepizole—ADH1A—head—head and neck cancer	0.00785	0.0259	CbGeAlD
Fomepizole—ADH1B—trachea—head and neck cancer	0.00776	0.0256	CbGeAlD
Fomepizole—CAT—lymphoid tissue—head and neck cancer	0.0075	0.0247	CbGeAlD
Fomepizole—ADH1B—Biological oxidations—NAT2—head and neck cancer	0.007	0.0149	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—NAT2—head and neck cancer	0.007	0.0149	CbGpPWpGaD
Fomepizole—CAT—thyroid gland—head and neck cancer	0.00681	0.0225	CbGeAlD
Fomepizole—ADH1B—lymphoid tissue—head and neck cancer	0.00676	0.0223	CbGeAlD
Fomepizole—CAT—Folate Metabolism—SOD2—head and neck cancer	0.00673	0.0143	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—GPX1—head and neck cancer	0.00642	0.0136	CbGpPWpGaD
Fomepizole—Nystagmus—Vinblastine—head and neck cancer	0.00638	0.0571	CcSEcCtD
Fomepizole—Application site reaction—Fluorouracil—head and neck cancer	0.00638	0.0571	CcSEcCtD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—BCL2—head and neck cancer	0.00618	0.0132	CbGpPWpGaD
Fomepizole—ADH1B—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00617	0.0131	CbGpPWpGaD
Fomepizole—ADH1C—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00617	0.0131	CbGpPWpGaD
Fomepizole—ADH1B—thyroid gland—head and neck cancer	0.00614	0.0202	CbGeAlD
Fomepizole—CAT—head—head and neck cancer	0.00604	0.0199	CbGeAlD
Fomepizole—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.00604	0.0541	CcSEcCtD
Fomepizole—CAT—Nucleotide metabolism—TYMS—head and neck cancer	0.00593	0.0126	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—NAT2—head and neck cancer	0.0058	0.0123	CbGpPWpGaD
Fomepizole—CAT—Nucleotide metabolism—GPX1—head and neck cancer	0.00561	0.0119	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00556	0.0118	CbGpPWpGaD
Fomepizole—ADH1A—lymph node—head and neck cancer	0.0055	0.0181	CbGeAlD
Fomepizole—ADH1B—head—head and neck cancer	0.00544	0.018	CbGeAlD
Fomepizole—ADH1C—lymph node—head and neck cancer	0.00539	0.0178	CbGeAlD
Fomepizole—CAT—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00534	0.0114	CbGpPWpGaD
Fomepizole—ADH1A—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00511	0.0109	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—GPX1—head and neck cancer	0.0051	0.0108	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—CCNA1—head and neck cancer	0.00463	0.00986	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—SOD2—head and neck cancer	0.0045	0.00958	CbGpPWpGaD
Fomepizole—Heartburn—Fluorouracil—head and neck cancer	0.00434	0.0389	CcSEcCtD
Fomepizole—CAT—lymph node—head and neck cancer	0.00423	0.014	CbGeAlD
Fomepizole—Nystagmus—Fluorouracil—head and neck cancer	0.00419	0.0375	CcSEcCtD
Fomepizole—Phlebitis—Vinblastine—head and neck cancer	0.00384	0.0344	CcSEcCtD
Fomepizole—ADH1B—lymph node—head and neck cancer	0.00381	0.0126	CbGeAlD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.0037	0.00786	CbGpPWpGaD
Fomepizole—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00352	0.00749	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—IL2—head and neck cancer	0.0035	0.00745	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TP53—head and neck cancer	0.0035	0.00744	CbGpPWpGaD
Fomepizole—ADH1A—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.00347	0.00739	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—GSTM1—head and neck cancer	0.00346	0.00736	CbGpPWpGaD
Fomepizole—ADH1B—Biological oxidations—GSTM1—head and neck cancer	0.00346	0.00736	CbGpPWpGaD
Fomepizole—ADH1B—Biological oxidations—CYP1A1—head and neck cancer	0.00328	0.00697	CbGpPWpGaD
Fomepizole—ADH1C—Biological oxidations—CYP1A1—head and neck cancer	0.00328	0.00697	CbGpPWpGaD
Fomepizole—Heartburn—Docetaxel—head and neck cancer	0.00314	0.0281	CcSEcCtD
Fomepizole—CAT—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.003	0.00638	CbGpPWpGaD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00297	0.00633	CbGpPWpGaD
Fomepizole—CYP2A6—Xenobiotics—CYP1A1—head and neck cancer	0.00295	0.00627	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—UROD—head and neck cancer	0.00288	0.00613	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—UROD—head and neck cancer	0.00288	0.00613	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—GSTM1—head and neck cancer	0.00287	0.0061	CbGpPWpGaD
Fomepizole—CYP2A6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00283	0.00603	CbGpPWpGaD
Fomepizole—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00278	0.00592	CbGpPWpGaD
Fomepizole—ADH1A—Biological oxidations—CYP1A1—head and neck cancer	0.00272	0.00578	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—BCL2—head and neck cancer	0.00266	0.00566	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00263	0.0056	CbGpPWpGaD
Fomepizole—CAT—Metabolism—UROD—head and neck cancer	0.0026	0.00552	CbGpPWpGaD
Fomepizole—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.00247	0.00524	CbGpPWpGaD
Fomepizole—CAT—FoxO family signaling—AKT1—head and neck cancer	0.00241	0.00512	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—UROD—head and neck cancer	0.00239	0.00508	CbGpPWpGaD
Fomepizole—CYP2E1—Xenobiotics—CYP1A1—head and neck cancer	0.00233	0.00495	CbGpPWpGaD
Fomepizole—Drowsiness—Hydroxyurea—head and neck cancer	0.00232	0.0208	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CCND1—head and neck cancer	0.00228	0.00486	CbGpPWpGaD
Fomepizole—Pharyngitis—Vinblastine—head and neck cancer	0.00227	0.0203	CcSEcCtD
Fomepizole—CAT—Folate Metabolism—TP53—head and neck cancer	0.00225	0.00478	CbGpPWpGaD
Fomepizole—CYP2E1—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00224	0.00476	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—SOD2—head and neck cancer	0.00222	0.00472	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PTEN—head and neck cancer	0.0022	0.00469	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—GPX1—head and neck cancer	0.00212	0.0045	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00211	0.00448	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—head and neck cancer	0.00209	0.00446	CbGpPWpGaD
Fomepizole—Lightheadedness—Docetaxel—head and neck cancer	0.00193	0.0173	CcSEcCtD
Fomepizole—Eosinophilia—Fluorouracil—head and neck cancer	0.00186	0.0166	CcSEcCtD
Fomepizole—Anaemia—Vinblastine—head and neck cancer	0.00184	0.0165	CcSEcCtD
Fomepizole—Phlebitis—Docetaxel—head and neck cancer	0.00182	0.0163	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—MAPK1—head and neck cancer	0.00179	0.00381	CbGpPWpGaD
Fomepizole—Vertigo—Vinblastine—head and neck cancer	0.00179	0.016	CcSEcCtD
Fomepizole—Convulsion—Vinblastine—head and neck cancer	0.00173	0.0155	CcSEcCtD
Fomepizole—Anaemia—Hydroxyurea—head and neck cancer	0.00168	0.015	CcSEcCtD
Fomepizole—Visual disturbance—Docetaxel—head and neck cancer	0.00165	0.0148	CcSEcCtD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.00165	0.00351	CbGpPWpGaD
Fomepizole—CYP2E1—lymphoid tissue—head and neck cancer	0.00161	0.00532	CbGeAlD
Fomepizole—Convulsion—Hydroxyurea—head and neck cancer	0.00157	0.0141	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PIK3CA—head and neck cancer	0.00156	0.00331	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TP53—head and neck cancer	0.0015	0.0032	CbGpPWpGaD
Fomepizole—Pharyngitis—Fluorouracil—head and neck cancer	0.00149	0.0133	CcSEcCtD
Fomepizole—CYP2E1—thyroid gland—head and neck cancer	0.00146	0.00483	CbGeAlD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—HRAS—head and neck cancer	0.00144	0.00306	CbGpPWpGaD
Fomepizole—Decreased appetite—Vinblastine—head and neck cancer	0.00141	0.0127	CcSEcCtD
Fomepizole—Pain—Vinblastine—head and neck cancer	0.00139	0.0124	CcSEcCtD
Fomepizole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00133	0.0119	CcSEcCtD
Fomepizole—Somnolence—Hydroxyurea—head and neck cancer	0.00132	0.0118	CcSEcCtD
Fomepizole—Dyspepsia—Hydroxyurea—head and neck cancer	0.0013	0.0117	CcSEcCtD
Fomepizole—CYP2E1—head—head and neck cancer	0.0013	0.00428	CbGeAlD
Fomepizole—Decreased appetite—Hydroxyurea—head and neck cancer	0.00129	0.0115	CcSEcCtD
Fomepizole—Abdominal pain—Vinblastine—head and neck cancer	0.00128	0.0115	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—AKT1—head and neck cancer	0.00127	0.0027	CbGpPWpGaD
Fomepizole—Pain—Hydroxyurea—head and neck cancer	0.00127	0.0114	CcSEcCtD
Fomepizole—Vision blurred—Fluorouracil—head and neck cancer	0.00123	0.011	CcSEcCtD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00122	0.0026	CbGpPWpGaD
Fomepizole—Anaemia—Fluorouracil—head and neck cancer	0.00121	0.0108	CcSEcCtD
Fomepizole—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00121	0.00257	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—NAT2—head and neck cancer	0.0012	0.00255	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—NAT2—head and neck cancer	0.0012	0.00255	CbGpPWpGaD
Fomepizole—CYP2E1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.0012	0.00254	CbGpPWpGaD
Fomepizole—Body temperature increased—Hydroxyurea—head and neck cancer	0.00117	0.0105	CcSEcCtD
Fomepizole—Convulsion—Fluorouracil—head and neck cancer	0.00113	0.0101	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.00113	0.00239	CbGpPWpGaD
Fomepizole—Diarrhoea—Vinblastine—head and neck cancer	0.00111	0.00996	CcSEcCtD
Fomepizole—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.00109	0.00232	CbGpPWpGaD
Fomepizole—CAT—Metabolism—NAT2—head and neck cancer	0.00108	0.00229	CbGpPWpGaD
Fomepizole—Pharyngitis—Docetaxel—head and neck cancer	0.00108	0.00964	CcSEcCtD
Fomepizole—Dizziness—Vinblastine—head and neck cancer	0.00107	0.00963	CcSEcCtD
Fomepizole—ADH1B—Metabolism—DPYD—head and neck cancer	0.00105	0.00223	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—DPYD—head and neck cancer	0.00105	0.00223	CbGpPWpGaD
Fomepizole—Visual impairment—Docetaxel—head and neck cancer	0.00104	0.00936	CcSEcCtD
Fomepizole—Tachycardia—Fluorouracil—head and neck cancer	0.00104	0.00933	CcSEcCtD
Fomepizole—Vomiting—Vinblastine—head and neck cancer	0.00103	0.00926	CcSEcCtD
Fomepizole—Headache—Vinblastine—head and neck cancer	0.00102	0.00912	CcSEcCtD
Fomepizole—Diarrhoea—Hydroxyurea—head and neck cancer	0.00101	0.00908	CcSEcCtD
Fomepizole—Flushing—Docetaxel—head and neck cancer	0.00101	0.00901	CcSEcCtD
Fomepizole—Hypotension—Fluorouracil—head and neck cancer	0.000997	0.00893	CcSEcCtD
Fomepizole—ADH1B—Metabolism—YAP1—head and neck cancer	0.000996	0.00212	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—YAP1—head and neck cancer	0.000996	0.00212	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—NAT2—head and neck cancer	0.000992	0.00211	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000992	0.00211	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—VEGFA—head and neck cancer	0.000981	0.00209	CbGpPWpGaD
Fomepizole—Dizziness—Hydroxyurea—head and neck cancer	0.00098	0.00878	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—STAT3—head and neck cancer	0.000972	0.00207	CbGpPWpGaD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000967	0.00206	CbGpPWpGaD
Fomepizole—Nausea—Vinblastine—head and neck cancer	0.000965	0.00865	CcSEcCtD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000954	0.00203	CbGpPWpGaD
Fomepizole—Somnolence—Fluorouracil—head and neck cancer	0.000948	0.0085	CcSEcCtD
Fomepizole—CAT—Metabolism—DPYD—head and neck cancer	0.000945	0.00201	CbGpPWpGaD
Fomepizole—Vomiting—Hydroxyurea—head and neck cancer	0.000942	0.00844	CcSEcCtD
Fomepizole—Dyspepsia—Fluorouracil—head and neck cancer	0.000939	0.00841	CcSEcCtD
Fomepizole—Rash—Hydroxyurea—head and neck cancer	0.000934	0.00837	CcSEcCtD
Fomepizole—Dermatitis—Hydroxyurea—head and neck cancer	0.000934	0.00836	CcSEcCtD
Fomepizole—Headache—Hydroxyurea—head and neck cancer	0.000928	0.00832	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—MAPK3—head and neck cancer	0.000928	0.00198	CbGpPWpGaD
Fomepizole—Decreased appetite—Fluorouracil—head and neck cancer	0.000927	0.00831	CcSEcCtD
Fomepizole—Dysgeusia—Docetaxel—head and neck cancer	0.000924	0.00828	CcSEcCtD
Fomepizole—Back pain—Docetaxel—head and neck cancer	0.000913	0.00817	CcSEcCtD
Fomepizole—Pain—Fluorouracil—head and neck cancer	0.000912	0.00817	CcSEcCtD
Fomepizole—CAT—Metabolism—YAP1—head and neck cancer	0.000897	0.00191	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—NAT2—head and neck cancer	0.000889	0.00189	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—MAPK1—head and neck cancer	0.000883	0.00188	CbGpPWpGaD
Fomepizole—Nausea—Hydroxyurea—head and neck cancer	0.00088	0.00789	CcSEcCtD
Fomepizole—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	0.000877	0.00187	CbGpPWpGaD
Fomepizole—Anaemia—Docetaxel—head and neck cancer	0.000872	0.00781	CcSEcCtD
Fomepizole—ADH1A—Metabolism—DPYD—head and neck cancer	0.00087	0.00185	CbGpPWpGaD
Fomepizole—Body temperature increased—Fluorouracil—head and neck cancer	0.000843	0.00755	CcSEcCtD
Fomepizole—ADH1A—Metabolism—YAP1—head and neck cancer	0.000826	0.00176	CbGpPWpGaD
Fomepizole—Convulsion—Docetaxel—head and neck cancer	0.000817	0.00732	CcSEcCtD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000784	0.00167	CbGpPWpGaD
Fomepizole—Shock—Docetaxel—head and neck cancer	0.000758	0.00679	CcSEcCtD
Fomepizole—Tachycardia—Docetaxel—head and neck cancer	0.000751	0.00673	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—TP53—head and neck cancer	0.000742	0.00158	CbGpPWpGaD
Fomepizole—Diarrhoea—Fluorouracil—head and neck cancer	0.00073	0.00654	CcSEcCtD
Fomepizole—Hypotension—Docetaxel—head and neck cancer	0.000719	0.00644	CcSEcCtD
Fomepizole—Dizziness—Fluorouracil—head and neck cancer	0.000705	0.00632	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000699	0.00149	CbGpPWpGaD
Fomepizole—Somnolence—Docetaxel—head and neck cancer	0.000684	0.00613	CcSEcCtD
Fomepizole—Vomiting—Fluorouracil—head and neck cancer	0.000678	0.00608	CcSEcCtD
Fomepizole—Dyspepsia—Docetaxel—head and neck cancer	0.000678	0.00607	CcSEcCtD
Fomepizole—Rash—Fluorouracil—head and neck cancer	0.000673	0.00603	CcSEcCtD
Fomepizole—Dermatitis—Fluorouracil—head and neck cancer	0.000672	0.00602	CcSEcCtD
Fomepizole—Decreased appetite—Docetaxel—head and neck cancer	0.000669	0.006	CcSEcCtD
Fomepizole—Headache—Fluorouracil—head and neck cancer	0.000668	0.00599	CcSEcCtD
Fomepizole—Pain—Docetaxel—head and neck cancer	0.000658	0.0059	CcSEcCtD
Fomepizole—Nausea—Fluorouracil—head and neck cancer	0.000634	0.00568	CcSEcCtD
Fomepizole—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.000634	0.00135	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00063	0.00564	CcSEcCtD
Fomepizole—Body temperature increased—Docetaxel—head and neck cancer	0.000609	0.00545	CcSEcCtD
Fomepizole—Abdominal pain—Docetaxel—head and neck cancer	0.000609	0.00545	CcSEcCtD
Fomepizole—ADH1B—Metabolism—TYMS—head and neck cancer	0.000598	0.00127	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—TYMS—head and neck cancer	0.000598	0.00127	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTM1—head and neck cancer	0.000591	0.00126	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTM1—head and neck cancer	0.000591	0.00126	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GPX1—head and neck cancer	0.000566	0.0012	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GPX1—head and neck cancer	0.000566	0.0012	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP1A1—head and neck cancer	0.000561	0.00119	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP1A1—head and neck cancer	0.000561	0.00119	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000556	0.00118	CbGpPWpGaD
Fomepizole—CAT—Metabolism—TYMS—head and neck cancer	0.000539	0.00115	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTM1—head and neck cancer	0.000532	0.00113	CbGpPWpGaD
Fomepizole—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000532	0.00113	CbGpPWpGaD
Fomepizole—Diarrhoea—Docetaxel—head and neck cancer	0.000527	0.00472	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000527	0.00112	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GPX1—head and neck cancer	0.00051	0.00108	CbGpPWpGaD
Fomepizole—Dizziness—Docetaxel—head and neck cancer	0.000509	0.00456	CcSEcCtD
Fomepizole—CAT—Metabolism—CYP1A1—head and neck cancer	0.000505	0.00107	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—TYMS—head and neck cancer	0.000496	0.00105	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTM1—head and neck cancer	0.00049	0.00104	CbGpPWpGaD
Fomepizole—Vomiting—Docetaxel—head and neck cancer	0.00049	0.00439	CcSEcCtD
Fomepizole—Rash—Docetaxel—head and neck cancer	0.000485	0.00435	CcSEcCtD
Fomepizole—Dermatitis—Docetaxel—head and neck cancer	0.000485	0.00434	CcSEcCtD
Fomepizole—Headache—Docetaxel—head and neck cancer	0.000482	0.00432	CcSEcCtD
Fomepizole—ADH1A—Metabolism—GPX1—head and neck cancer	0.000469	0.000998	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CYP1A1—head and neck cancer	0.000465	0.000988	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—UROD—head and neck cancer	0.000463	0.000986	CbGpPWpGaD
Fomepizole—Nausea—Docetaxel—head and neck cancer	0.000457	0.0041	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000439	0.000934	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000433	0.000921	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000416	0.000886	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000411	0.000873	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—UROD—head and neck cancer	0.000366	0.000779	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTGS2—head and neck cancer	0.000333	0.000709	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTGS2—head and neck cancer	0.000333	0.000709	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTGS2—head and neck cancer	0.0003	0.000639	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTEN—head and neck cancer	0.000291	0.000619	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTEN—head and neck cancer	0.000291	0.000619	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTGS2—head and neck cancer	0.000276	0.000588	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTEN—head and neck cancer	0.000262	0.000557	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTEN—head and neck cancer	0.000241	0.000513	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PIK3CA—head and neck cancer	0.000205	0.000436	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PIK3CA—head and neck cancer	0.000205	0.000436	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—NAT2—head and neck cancer	0.000192	0.000409	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PIK3CA—head and neck cancer	0.000185	0.000393	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PIK3CA—head and neck cancer	0.00017	0.000362	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—DPYD—head and neck cancer	0.000169	0.000359	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—AKT1—head and neck cancer	0.000168	0.000356	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—AKT1—head and neck cancer	0.000168	0.000356	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—YAP1—head and neck cancer	0.00016	0.000341	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—NAT2—head and neck cancer	0.000152	0.000323	CbGpPWpGaD
Fomepizole—CAT—Metabolism—AKT1—head and neck cancer	0.000151	0.000321	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—AKT1—head and neck cancer	0.000139	0.000295	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—DPYD—head and neck cancer	0.000133	0.000284	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—YAP1—head and neck cancer	0.000127	0.000269	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—TYMS—head and neck cancer	9.61e-05	0.000205	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTM1—head and neck cancer	9.5e-05	0.000202	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GPX1—head and neck cancer	9.1e-05	0.000194	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP1A1—head and neck cancer	9.01e-05	0.000192	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—TYMS—head and neck cancer	7.6e-05	0.000162	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTM1—head and neck cancer	7.51e-05	0.00016	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GPX1—head and neck cancer	7.19e-05	0.000153	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP1A1—head and neck cancer	7.12e-05	0.000151	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTGS2—head and neck cancer	5.36e-05	0.000114	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTEN—head and neck cancer	4.67e-05	9.94e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTGS2—head and neck cancer	4.23e-05	9.01e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTEN—head and neck cancer	3.69e-05	7.86e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PIK3CA—head and neck cancer	3.3e-05	7.01e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—AKT1—head and neck cancer	2.69e-05	5.73e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PIK3CA—head and neck cancer	2.6e-05	5.54e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—AKT1—head and neck cancer	2.13e-05	4.53e-05	CbGpPWpGaD
